Anna Antonell - Concepedia

Author

Anna Antonell

Consorci Institut D'Investigacions Biomediques August Pi I Sunyer ORCID

Also Known As

A. Antonell, Albert Lladó, Anna Antonell, Anna M. Sucarrats Antonell, Antonell, A., Antonell, Anna, Christin Andersson, Mircea Balasa, Rainer Malik, Vesna Jelic

Publications

4.1K

Citations

H-Index

Concepts

All Affiliations

Consorci Institut D'Investigacions Biomediques August Pi I Sunyer Universitat de Barcelona Hospital Clínic de Barcelona Biomedical Research Networking Center on Neurodegenerative Diseases University College London

About

Anna Antonell is an author at Consorci Institut D'Investigacions Biomediques August Pi I Sunyer specializing in medicine, neurology, and neuroscience.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	12	1.3K
2	Social Sciences	3	3	670
3	Public Health	2	2	48
4	Health Sciences	1	1	18
5	Biostatistics	1	1	30

Anna Antonell

Publications

3.5K

Citations

H-Index

Page 1

	Year	Citations
TREM2 mutations implicated in neurodegeneration impair cell surface transport and phagocytosis Gernot Kleinberger, Yoshinori Yamanishi, Marc Suárez‐Calvet, Science Translational Medicine	2014	805
<scp>sTREM</scp> 2 cerebrospinal fluid levels are a potential biomarker for microglia activity in early‐stage Alzheimer's disease and associate with neuronal injury markers Marc Suárez‐Calvet, Gernot Kleinberger, Miguel Ángel Araque Caballero, EMBO Molecular Medicine ImmunologyNeurochemical BiomarkersSocial SciencesNeuroinflammationCsf Levels	2016	503
Low cerebrospinal fluid concentration of mitochondrial DNA in preclinical Alzheimer disease Petar Podlesniy, Joana Figueiro‐Silva, Albert Lladó, Annals of Neurology	2013	217
Serum neurofilament light chain in genetic frontotemporal dementia: a longitudinal, multicentre cohort study Emma L. van der Ende, Lieke Meeter, Jackie M. Poos, The Lancet Neurology Alzheimer's DiseaseGenetic Frontotemporal DementiaOphthalmologyDementiaMulticentre Cohort Study	2019	179
Plasma miR-34a-5p and miR-545-3p as Early Biomarkers of Alzheimer’s Disease: Potential and Limitations Marta Cosín‐Tomás, Anna Antonell, Albert Lladó, Molecular Neurobiology Neurodegenerative DiseasesEarly BiomarkersMolecular NeuroscienceAlzheimer's DiseaseBiomarkers	2016	150
Identification of blood serum micro‐RNAs associated with idiopathic and <i>LRRK2</i> Parkinson's disease Teresa Botta‐Orfila, Xavier Morató, Yaroslau Compta, Journal of Neuroscience Research Neurodegenerative DiseasesBlood Serum Micro‐rnasNucleic Acid BiomarkersPd Patients CarriersMedicine	2014	144
CSF biomarkers for the differential diagnosis of Alzheimer's disease: A large‐scale international multicenter study Michael Ewers, Niklas Mattsson, Lennart Minthon, Alzheimer s & Dementia	2015	125
Assessing the role of the TREM2 p.R47H variant as a risk factor for Alzheimer's disease and frontotemporal dementia Oriol Dols‐Icardo, María J. Bullido, Pau Pástor, Neurobiology of Aging Alzheimer's DiseaseDementiaPathologyRisk FactorVascular Dementia	2013	119
Characterization of the repeat expansion size in C9orf72 in amyotrophic lateral sclerosis and frontotemporal dementia Oriol Dols‐Icardo, Alberto García‐Redondo, Ricard Rojas‐García, Human Molecular Genetics	2013	108
Serum neurofilament light levels correlate with severity measures and neurodegeneration markers in autosomal dominant Alzheimer’s disease Raquel Sánchez‐Valle, Amanda Heslegrave, Martha Foiani, Alzheimer s Research & Therapy	2018	80

Page 1